Παραπομπή σε μορφή APA (7η εκδ.)

Preiss, D., Herrington, W., & Haynes, R. (2022). Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: The EMPA-KIDNEY trial. American Heart Association.

Παραπομπή σε μορφή Chicago (17η εκδ.)

Preiss, D., W. Herrington, και R. Haynes. Empagliflozin and Cardiovascular Outcomes in Patients with Chronic Kidney Disease: The EMPA-KIDNEY Trial. American Heart Association, 2022.

Παραπομπή σε μορφή MLA (9th εκδ.)

Preiss, D., et al. Empagliflozin and Cardiovascular Outcomes in Patients with Chronic Kidney Disease: The EMPA-KIDNEY Trial. American Heart Association, 2022.